Immunovia publishes the annual report for the financial year 2018
LUND, SWEDEN - Immunovia has today published the annual report for 2018 in Swedish. It is available on Immunovia's website. Mats Grahn, CEO, comments: "We entered 2018 with the continued mission to develop and validate accurate blood-based diagnostic tests and moved towards the exciting activities to commercialize those efforts. We completed the expansion of our production and sample testing facilities, IMMray™ Dx Laboratories, at our headquarters in Lund, Sweden, we advanced our important clinical collaborations and entered into new ones, our shares began trading on Nasdaq Stockholm main